07:00 , Aug 2, 1999 |  BC Week In Review  |  Clinical News

BioGlue surgical adhesive regulatory update

CRY submitted applications for Australian and Canadian marketing approval for its BioGlue as a surgical adhesive in vascular and pulmonary sealing and repair. CryoLife Inc. (CRY), Atlanta, Ga.   Product: BioGlue surgical adhesive   Business: Biomaterial/Skin/Wound...
07:00 , May 10, 1999 |  BC Week In Review  |  Clinical News

CryoLife regulatory update

CRY filed a 510(k) with the FDA for its BioGlue surgical patch to reinforce and seal the soft tissues of the lungs and bronchi to reduce air leaks during reconstructive surgery. CryoLife Inc. (CRY),...
07:00 , Apr 26, 1999 |  BC Week In Review  |  Clinical News

CryoLife preclinical data

CRY collaborators showed that the use of BioGlue to reconnect saphenous vein grafts and internal mammary arteries during cardiac bypass surgery in goats allowed the vessels to remain open and normal up to 12 months...
08:00 , Mar 22, 1999 |  BC Week In Review  |  Clinical News

CryoLife regulatory update

CRY received CE mark approval to distribute in the European Union its BioGlue protein-based surgical adhesive for pulmonary applications, including sealing of tracheal, esophageal and lung incisions. CryoLife Inc. (CRY), Atlanta, Ga.   Business:...
07:00 , Sep 11, 1995 |  BC Week In Review  |  Company News

CryoLife other research news

The Atlanta company received a Phase I SBIR from the Department of Health and Human Services to develop CRYL's BioGlue, a plasma protein-based bioadhesive, to replace sutures and staples in surgery and wound repair....